genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Cancer
Tumors Exploit Link between Chromosome Chaos and Immune Dysregulation
Antibodies
Using RNAi to Produce More Effective Biotherapeutic Antibodies
CRISPR
Vertex, Mammoth Launch Up-to-$695M CRISPR Gene-Editing Collaboration
Neuroscience
Placebo Effect Might Not Be All in Your Head
Antibacterials
Study Reveals Complex Architecture of Membrane That Protects Some Deadly Bacteria…
Insights
All
Trends for 2020
Trends for 2021
Antibodies
Monoclonal Firms Can Help Gene Therapy Sector Deal with HCPs
Bioprocessing
ElevateBio Plans to Expand Advanced Therapy Knowledge-Sharing Facilities
Antibodies
Using RNAi to Produce More Effective Biotherapeutic Antibodies
10x Genomics
Single-Cell RNA Sequencing May Be Split By Parse Biosciences
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Coronavirus
Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 10 Synthetic Biology Companies
A-Lists
Seven Up-and-Coming COVID-19 Drugs
A-Lists
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Novartis
Novartis
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Novartis
Bleeding Edge: Anthos Pursues a Monthly Anticoagulant
Novartis
Mountain Climbing: Dyno Fights AAV Vector Immune Response with $100M
Novartis
Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration
Novartis
Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’
Novartis
A New Vision for Gene Therapy
Novartis
Novartis Taps Sangamo Zinc Finger Tech for Gene Regulation Therapies
Novartis
Dyno Inks Up to $2B+ in Gene Therapy Partnerships with Novartis,...
Novartis
Novartis Plans Phase III Trial of Hydroxychloroquine for COVID-19
Novartis
FDA Places Partial Clinical Hold on Some Trials of Novartis Gene...
Novartis
MorphoSys, Galapagos Halt Development of Atopic Dermatitis Candidate Licensed to Novartis
Novartis
Novartis, Microsoft Launch AI Collaboration
Novartis
Novartis Gains Option to Acquire Second IFM Subsidiary in Up-to-$840M cGAS/STING...
Novartis
Gilead Grows Antiviral Pipeline with Novartis, DURECT Licensing Deals
Novartis
AveXis Turns to Catalent’s Paragon for Additional Gene Therapy Manufacturing Capacity
Scroll Up
